Company Panpharma Med Srl with Fiscal Code 32245084
recorded a turnover of 2024 of
1.124.933,
with a net profit of
5.435
and having an average number of employees of
7.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Panpharma Med Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
3.587.487
7.712.427
7.502.504
8.661.106
1.875.276
779.760
611.683
778.422
1.048.739
1.124.933
Total Income - EUR
3.659.119
7.712.442
7.503.374
8.972.526
2.312.224
822.232
617.509
786.198
1.073.794
1.170.412
Total Expenses - EUR
3.640.775
7.681.063
7.531.174
8.962.998
2.140.274
879.415
669.277
822.521
1.090.084
1.164.715
Gross Profit/Loss - EUR
18.345
31.379
-27.800
9.527
171.950
-57.183
-51.768
-36.322
-16.291
5.697
Net Profit/Loss - EUR
15.084
26.214
-48.195
9.527
152.541
-57.183
-52.053
-36.322
-16.291
5.435
Employees
17
24
31
24
17
7
5
6
7
7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 7.9%, from 1.048.739 euro in the year 2023, to 1.124.933 euro in 2024.
The Net Profit increased by 5.435 euro, from 0 euro in 2023, to 5.435 in the last year.
Check the financial reports for the company - Panpharma Med Srl
Financial Rating - PANPHARMA MED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Panpharma Med Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Panpharma Med Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Panpharma Med Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Panpharma Med Srl - CUI 32245084
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
824.794
910.064
793.265
674.407
578.047
544.310
512.477
450.253
434.584
416.949
Current Assets
2.237.848
2.271.678
2.663.760
2.728.317
1.900.408
902.865
959.637
1.107.983
1.850.119
1.502.240
Inventories
641.840
717.272
1.220.076
311.774
303.679
115.263
122.218
119.965
175.226
154.065
Receivables
1.474.108
1.107.473
1.386.713
1.929.107
1.593.440
781.398
829.445
982.277
1.665.954
1.338.523
Cash
121.900
446.933
56.972
487.435
3.290
6.204
7.974
5.741
8.938
9.652
Shareholders Funds
15.317
26.348
-48.060
-37.650
283.024
220.475
163.533
127.718
106.380
111.220
Social Capital
112
111
114
112
167.514
164.338
160.694
161.192
160.704
159.805
Debts
3.047.393
3.164.331
3.513.207
3.440.951
2.196.108
1.227.110
1.308.904
1.430.843
2.178.708
1.808.080
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.502.240 euro in 2024 which includes Inventories of
154.065 euro, Receivables of
1.338.523 euro and cash availability of
9.652 euro.
The company's Equity was valued at
111.220 euro, while total Liabilities amounted to
1.808.080 euro.
Equity increased by 5.435 euro, from 106.380 euro in 2023, to 111.220 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Panpharma Med Srl